dr. reddy's labs glp-1 receptor agonist Laboratories has entered the fast-growing therapy segment with the launch of its semaglutide generic, Obeda, for Type 2 diabetes in India's โน1,446 crore market. ๐๐๐๐ ๐๐ฎ๐ฅ๐ฅ ๐๐ซ๐ญ๐ข๐๐ฅ๐ ๐จ๐ง ๐จ๐ฎ๐ซ Dr Reddy's Laboratories launches generic
Pay in 4 interest-free payments of $6.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 14 - Aug 19






.webp)







.png)









_(1)44368228eb044342af44e53832b68ca4.png)





